The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Samuel R. Denmeade

Department of Oncology

The Johns Hopkins University School of Medicine

Cancer Research Building I

Rm 1M43

[email]@jhmi.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Oncology, The Johns Hopkins University School of Medicine, Cancer Research Building I, Rm 1M43. 2012
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA. 2002 - 2010

References

  1. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug. Brennen, W.N., Rosen, D.M., Wang, H., Isaacs, J.T., Denmeade, S.R. J. Natl. Cancer Inst. (2012) [Pubmed]
  2. Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy. Brennen, W.N., Isaacs, J.T., Denmeade, S.R. Mol. Cancer Ther. (2012) [Pubmed]
  3. Bipolar androgen therapy: the rationale for rapid cycling of supraphysiologic androgen/ablation in men with castration resistant prostate cancer. Denmeade, S.R., Isaacs, J.T. Prostate (2010) [Pubmed]
  4. The SERCA pump as a therapeutic target: making a "smart bomb" for prostate cancer. Denmeade, S.R., Isaacs, J.T. Cancer Biol. Ther. (2005) [Pubmed]
  5. Development of prostate cancer treatment: the good news. Denmeade, S.R., Isaacs, J.T. Prostate (2004) [Pubmed]
  6. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models. Denmeade, S.R., Sokoll, L.J., Dalrymple, S., Rosen, D.M., Gady, A.M., Bruzek, D., Ricklis, R.M., Isaacs, J.T. Prostate (2003) [Pubmed]
  7. Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells in vitro or prostate cancer xenografts in vivo. Denmeade, S.R., Litvinov, I., Sokoll, L.J., Lilja, H., Isaacs, J.T. Prostate (2003) [Pubmed]
  8. Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer. Denmeade, S.R., Jakobsen, C.M., Janssen, S., Khan, S.R., Garrett, E.S., Lilja, H., Christensen, S.B., Isaacs, J.T. J. Natl. Cancer Inst. (2003) [Pubmed]
  9. A history of prostate cancer treatment. Denmeade, S.R., Isaacs, J.T. Nat. Rev. Cancer (2002) [Pubmed]
 
WikiGenes - Universities